Strategies for overcoming Antimicrobial Resistance.pptx

frozencaveman2 224 views 16 slides Jun 01, 2024
Slide 1
Slide 1 of 16
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16

About This Presentation

Mechanism of antimicrobial resistance and possible approaches to fight against it worldwide.


Slide Content

Strategies for overcoming drug resistance in antimicrobial therapy Prepared by: SAYANTAN KUNDU (M.PHARM,PHARMACOLOGY) Roll No.: PG/06/MPHARMP/2023/022 Enrollment No.: AU/2023/0010463 SCHOOL OF HEALTH & MEDICAL SCIENCES ADAMAS UNIVERSITY KOLKATA-700126

CONTENT INTRODUCTION FACTORS CONTRIBUTING TO AMR MECHANISM OF AMR HOW AMR SPREAD RECENT APPROACHES TO DOWNPLAYING AMR STRATEGIES TO COMBAT ANTIBIOTIC RESISTANCE

Types Anti Microbial resistance (AMR) Antimicrobial resistance (AMR) is an ability of a microorganism (bacteria, viruses and some parasites) to stop an antimicrobials (antibiotics, antivirals, anti- malarials ) from working against it. Any antimicrobial treatment becomes ineffective as infections persist and may spread to others. This is responsible for millions of death worldwide andis concerned as major public health concernnowadays . Introduction

Factor contributing to Anti-Microbial resistance Environmental Factors 1. Huge populations and overcrowding 2. Rapid spread - increased travelling 3. Poor sanitation 4. Increases community acquired resistance Drug Related Factors 1. Fake drugs. 2. Quality of the drug. 3. Soaring use of antibiotics. 4.Over the counter availability of antimicrobials. Patient Related Factors 1. Poor adherence of dosage Regimens 2. Poverty. 3. Lack of sanitation concept. 4. Lack of education. 5. Self-medication. 6. Misconception. Physician / Prescriber Related Factors 1. Inappropriate use of available drugs. 2. Increased empiric poly-antimicrobial use. 3. Overuse of antimicrobials. 4. Inadequate dosing. 5. Lack of current knowledge and training.

Mechanism of Anti-microbial drug resistance Enzymatic inactivation: An existing bacterial enzyme is modified to interact with an antibiotic in order to make them inactive towards bacteria. It is due to the transfer of the antibiotic resistance gene carried on plasmids. The most significant examples are beta-lactamase enzymes, which hydrolyze beta-lactams ( penicillins , cephalosporins). Drug extrusion by efflux pumps: These proteins, which are able to extrude a wide variety of compounds (including antibiotics) out of the cell, are overexpressed by the bacteria to extrude the antibiotic. This is an important mechanism of resistance in P. aeruginosa and Acinetobacter spp. Decreased uptake by changes in the outer membrane permeability or by presence of porins: These variations interfere with the entrance of antibiotics. Modification of the drug target: These changes impede the binding of the antibiotic and limit its potency.

Recent Approaches for Downplaying Antibiotic Resistance: Molecular Mechanisms

1. Cutting Edge Methodologies to Manipulate Antimicrobial Resistance 1.1. New Antibiotic discovery 1 .2. Antibiotic Adjuvants for the Inhibition of Resistance

2 . Prioritized Other Modern and Novel Alternative Therapies 2.1 Antivirulent Therapy/Quorum-Sensing Inhibitors 2.2. Passive Immunization (Monoclonal Antibodies) 2.3. Phage Therapy 2.4. Nanoparticles

2.5 . Phytochemicals 2.6. Vaccination 2.7. Antimicrobial Peptides

Call for action

Strategies to combat drug resistance in antibiotics: International Measure Increased collaboration between governments, non-governmental organizations, professional groups and international agencies. New networks that undertake surveillance of antimicrobials use of AMR. International approach for control of counterfeit antimicrobials. Incentive for the research and development of new drugs and vaccines. Forming new and reinforcing existing programmes  to certain AMR National strategies: WHO recommends that such committee would formulate AMR policy Provide guidance on standards, regulations, training and awareness onantibiotic use and AMR. Establishing and implementing national standard treatment guideline, having essential drug list (EDL) National Antimicrobial Resistance Policy, India: To understand emergence, spreads and factors influencing AMR, to setup antimicrobial program.

Action at Community level Rational use of antibiotics. Over-the-counter (OTC) antibiotics. Standards of hygiene. Establishing an infection prevention and control committee (IPC). Good hand hygiene practices. Effective diagnosis and treatment of infection Surveillance of antibiotic resistance and antibiotic use. Improving the antimicrobial quality and supply chain. Good Microbiology Practices. Other Approaches Improve and strengthen surveillance and laboratory capacity and facilities Make sure uninterrupted wide access to essential medicines of assured quality Regulate and encourage rational use of medicines, even in animal husbandry, and ensure proper patient care. Improvise on infection prevention and control. Promote and pursue innovations and research and development for new tools. Other Measures

Conclusion In conclusion, addressing antimicrobial drug resistance requires a multifaceted approach that encompasses various strategies at both individual and societal levels. Through prudent antimicrobial use, enhanced surveillance, development of new drugs, implementation of infection prevention and control measures, and promoting public awareness, we can mitigate the growing threat of antimicrobial resistance. Collaboration between healthcare professionals, researchers, policymakers, and the public is crucial to effectively combat this global health challenge. By adopting comprehensive and sustainable strategies, we can preserve the effectiveness of antimicrobial drugs and safeguard the health of current and future generations.

References Ahmed S, Ahmed MZ, Rafique S, Almasoudi SE, Shah M, Jalil NA, Ojha SC. Recent approaches for downplaying antibiotic resistance: molecular mechanisms. BioMed Research International. 2023 Jan 23;2023. Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ. Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet. 2016 Jan 9;387(10014):176-87. Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspectives in medicinal chemistry. 2014 Jan;6:PMC-S14459. Tartari E, Abbas M, Pires D, De Kraker ME, Pittet D. World Health Organization SAVE LIVES: Clean Your Hands global campaign—‘Fight antibiotic resistance—it's in your hands'. Clinical Microbiology and Infection. 2017 Sep 1;23(9):596-8. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards Jr J, Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clinical infectious diseases. 2008 Jan 15;46(2):155-64. Cantón R, Morosini MI. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS microbiology reviews. 2011 Sep 1;35(5):977-91. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet infectious diseases. 2016 Feb 1;16(2):161-8.